A phase I trial of gemcitabine administered as a 96-h continuous intravenous infusion in patients with advanced carcinoma and lymphoma

Lakshmi Rajdev, Gary Goldberg, Una Hopkins, Joseph A. Sparano

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I trial of gemcitabine administered as a 96-h continuous intravenous infusion in patients with advanced carcinoma and lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences